The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...
The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.
Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...
NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the ...
Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...
A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...
6hon MSN
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug ...
Novavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor ...
Highlights,Novavax faces a clinical hold following the report of motor neuropathy in a trial participant nearly two years ...
Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and ...
On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback